Critical Contrast: Upexi (NASDAQ:GRVI) and Paranovus Entertainment Technology (NASDAQ:PAVS)

Upexi (NASDAQ:GRVI) and Paranovus Entertainment Technology (NASDAQ:PAVS) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, earnings, profitability, analyst recommendations, risk, institutional ownership and valuation.

Analyst Recommendations

This is a breakdown of recent recommendations and price targets for Upexi and Paranovus Entertainment Technology, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Upexi	0	0	0	0	N/A
Paranovus Entertainment Technology	0	0	0	0	N/A

Earnings and Valuation

This table compares Upexi and Paranovus Entertainment Technology’s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Upexi	$40.03 million	0.75	$2.98 million	N/A	N/A
Paranovus Entertainment Technology	$98.15 million	0.26	-$71.74 million	N/A	N/A

Upexi has higher earnings, but lower revenue than Paranovus Entertainment Technology.

Profitability

This table compares Upexi and Paranovus Entertainment Technology’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Upexi	8.10%	12.48%	10.39%
Paranovus Entertainment Technology	N/A	N/A	N/A

Risk and Volatility

Upexi has a beta of 1.23, meaning that its share price is 23% more volatile than the S&P 500. Comparatively, Paranovus Entertainment Technology has a beta of 0.18, meaning that its share price is 82% less volatile than the S&P 500.

Insider & Institutional Ownership

1.8% of Upexi shares are owned by institutional investors. Comparatively, 0.5% of Paranovus Entertainment Technology shares are owned by institutional investors. 55.0% of Upexi shares are owned by insiders. Comparatively, 15.6% of Paranovus Entertainment Technology shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Summary

Upexi beats Paranovus Entertainment Technology on 8 of the 9 factors compared between the two stocks.

About Upexi

Grove, Inc., through its subsidiaries, engages in developing, producing, marketing, and selling raw materials, white label products, and end consumer products containing the industrial hemp plant extract, cannabidiol. The company serves consumer markets, including the botanical, beauty care, pet care, and functional food sectors. It also operates annual tradeshow related to the CBD industry in the United States. The company was incorporated in 2018 and is headquartered in Henderson, Nevada.

About Paranovus Entertainment Technology

Paranovus Entertainment Technology Ltd. engages in the research, development, manufacture, and sale of nutraceutical and dietary supplement products in the People's Republic of China and internationally. The company's product category includes lucidum spore powders, cordyceps mycelia, Ejiao products, American ginseng products, other traditional Chinese herbal and animal extracts, vitamins, minerals, and amino acids. It also offers product marketing and e-commerce agency operation services under the Happy Buy platform to small and middle size businesses; and e-commerce solutions, internet information, and advertising services to the online stores or manufactures. In addition, the company provides secure transaction environment, automobile procurement, and financial services for automobile manufacturers under the Taochejun automobile sales platform. It sells its products through distributors, large-scale chain drugstores, malls, and supermarkets under the Happiness brand. The company was formerly known as Happiness Development Group Limited and changed its name to Paranovus Entertainment Technology Ltd. in March 2023. The company was founded in 2004 and is headquartered in Nanping, the People's Republic of China.